Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-03-26 @ 3:20 PM
NCT ID:
NCT07347002
Eligibility Criteria:
Inclusion Criteria:
1. Have place of residence in a municipality where the pilot vaccination strategy is implemented;
2. Are in an eligible age-group to receive the VLA1553 vaccine;
3. Have been notified in SINAN as a suspected case for CHIK or Dengue surveillance during the study period;
4. Have a sample registered in GAL that is collected within 0-5 days following the onset of CHIKV-like symptoms and is tested for CHIKV using RT-PCR;
5. Have complete data in the Brazilian MoH databases (SINAN and GAL) on age, sex, municipality of residence, sample collection date, and date of symptom onset and the healthcare facilities where the suspected case was reported.
Exclusion Criteria:
1. Have inconclusive RT-PCR result for CHIKV;
2. Have the first CHIKV-like symptom onset less than 14 days from date of vaccination.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
59 Years
Study:
NCT07347002
Study Brief:
Protocol Section:
NCT07347002